InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Lew
2 Mar 2026
EVP & Chief Financial Officer
Sell
5,565
$5.42
$30.16K
Dean Richard Artis
2 Mar 2026
EVP & Chief Scientific Officer
Sell
5,894
$5.43
$32.00K
Ted Yednock
2 Mar 2026
EVP & Chief Innovation Officer
Sell
5,566
$5.42
$30.17K
Michael Overdorf
2 Mar 2026
EVP & Chief Business Officer
Sell
4,339
$5.42
$23.52K
Jamie Dananberg
2 Mar 2026
Chief Medical Officer
Sell
5,820
$5.43
$31.60K
Michael Overdorf
18 Feb 2026
EVP & Chief Business Officer
Sell
6,225
$5.10
$31.75K
Ted Yednock
18 Feb 2026
EVP & Chief Innovation Officer
Sell
7,857
$5.11
$40.15K
Dean Richard Artis
18 Feb 2026
EVP & Chief Scientific Officer
Sell
5,290
$5.10
$26.98K
Jennifer Lew
18 Feb 2026
EVP & Chief Financial Officer
Sell
7,851
$5.11
$40.12K
Jamie Dananberg
18 Feb 2026
Chief Medical Officer
Sell
5,290
$5.10
$26.98K
Michael Overdorf
14 Jul 2025
EVP & Chief Business Officer
Sell
853
$2.61
$2.23K
Jennifer Lew
14 Jul 2025
EVP & Chief Financial Officer
Sell
1,117
$2.58
$2.88K
Ted Yednock
14 Jul 2025
EVP & Chief Innovation Officer
Sell
1,116
$2.58
$2.88K
Jennifer Lew
18 Feb 2025
EVP & Chief Financial Officer
Sell
6,912
$2.92
$20.18K
Michael Overdorf
18 Feb 2025
EVP & Chief Business Officer
Sell
6,618
$2.95
$19.52K
Ted Yednock
18 Feb 2025
EVP & Chief Innovation Officer
Sell
8,345
$2.91
$24.28K
Dean Richard Artis
18 Feb 2025
EVP & Chief Scientific Officer
Sell
5,515
$2.97
$16.38K
Jamie Dananberg
18 Feb 2025
Chief Medical Officer
Sell
5,521
$2.96
$16.34K
Ted Yednock
13 Feb 2025
EVP & Chief Innovation Officer
Sell
1,783
$2.99
$5.33K
Michael Overdorf
13 Feb 2025
EVP & Chief Business Officer
Sell
1,425
$2.99
$4.26K
Jennifer Lew
13 Feb 2025
EVP & Chief Financial Officer
Sell
1,786
$2.98
$5.32K
Douglas Love
13 Feb 2025
President and CEO
Sell
5,021
$2.95
$14.81K
Ted Yednock
15 Jul 2024
EVP & Chief Innovation Officer
Sell
1,106
$6.02
$6.66K
Jennifer Lew
15 Jul 2024
EVP & Chief Financial Officer
Sell
1,104
$6.03
$6.66K
Michael Overdorf
15 Jul 2024
EVP & Chief Business Officer
Sell
784
$6.02
$4.72K
Michael Overdorf
20 Feb 2024
EVP & Chief Business Officer
Sell
1,951
$5.48
$10.69K
Ted Yednock
20 Feb 2024
EVP & Chief Innovation Officer
Sell
2,604
$5.51
$14.35K
Jennifer Lew
20 Feb 2024
EVP & Chief Financial Officer
Sell
2,593
$5.53
$14.34K
Ted Yednock
12 Feb 2024
EVP & Chief Innovation Officer
Sell
1,810
$5.54
$10.03K
Jennifer Lew
12 Feb 2024
EVP & Chief Financial Officer
Sell
1,809
$5.54
$10.02K
Douglas Love
12 Feb 2024
President and CEO
Sell
5,782
$5.54
$32.03K
Michael Overdorf
12 Feb 2024
EVP & Chief Business Officer
Sell
1,349
$5.53
$7.46K
Jennifer Lew
11 Jul 2023
EVP & Chief Financial Officer
Sell
1,057
$3.84
$4.05K
Michael Overdorf
11 Jul 2023
EVP & Chief Business Officer
Sell
978
$3.84
$3.75K
Douglas Love
15 Feb 2023
President & CEO
Sell
6,571
$5.87
$38.56K
Jennifer Lew
14 Feb 2023
EVP & Chief Financial Officer
Sell
166
$6.30
$1.05K
Michael Overdorf
14 Feb 2023
EVP & Chief Business Officer
Sell
144
$6.30
$907.10
Jennifer Lew
13 Feb 2023
EVP & Chief Financial Officer
Sell
1,742
$6.31
$10.99K
Michael Overdorf
13 Feb 2023
EVP & Chief Business Officer
Sell
1,501
$6.30
$9.46K
Show all 111 transactions →

What was left out

Form 4 filings counted 172
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020